No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
EW240621C80000
- 10.19
- +3.29+47.68%
15min DelayClose Jun 20 15:59 ET
10.22High7.60Low
8.77Open6.90Pre Close13 Volume539 Open Interest80.00Strike Price11.88KTurnover164.51%IV1.52%PremiumJun 21, 2024Expiry Date8.84Intrinsic Value100Multiplier1DDays to Expiry1.35Extrinsic Value100Contract SizeAmericanOptions Type0.8882Delta0.0239Gamma9.55Leverage Ratio-0.4591Theta0.0021Rho8.48Eff Leverage0.0092Vega
Intraday
- 5D
- Daily
News
Edwards Lifesciences(EW.US) Officer Sells US$48,150 in Common Stock
$Edwards Lifesciences(EW.US)$ Officer Lippis Daniel J. sold 535 shares of common stock on Jun 20, 2024 at an average price of $90 for a total value of $48,150.Source: Announcement What is statement of
Edwards Lifesciences(EW.US) Officer Sells US$492.26K in Common Stock
$Edwards Lifesciences(EW.US)$ Officer Ullem Scott B. sold 5,625 shares of common stock on Jun 20, 2024 at an average price of $87.5125 for a total value of $492.26K.Source: Announcement What is statem
Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing
Scott B. Ullem, Corporate Vice President, Chief Financial Officer, on June 20, 2024, sold 5,625 shares in Edwards Lifesciences (EW) for $492,258. Following the Form 4 filing with the SEC, Ullem has co
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.47% on an annualized basis producing an average annual return of 18.64%. Currently, Edwards Lifesciences has a m
Edwards Lifesciences Stock: Is EW Underperforming the Healthcare Sector?
Investors in Edwards Lifesciences (NYSE:EW) Have Seen Favorable Returns of 42% Over the Past Five Years
Comments
Edwards Lifesciences' impressive ROCE history and its ability to generate high returns on increasing amounts of capital employed indicate strong fundamentals. This warrants further research into the stock despite it being more 'expensive' than before.
Edwards Lifesciences (NYSE:EW) Is Aiming To Keep Up Its Impressive ReturnsAnalysts reconfirmed revenue and earnings forecasts for Edwards Lifesciences, indicating no major change in business expectations following recent results. The price target increase suggests analysts believe the business's intrinsic value is improving.
Investors banking on Edwards Lifesciences' high P/E ratio might face a challenge as the firm's predicted market-aligned growth hints at a potential share price decline.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Align Technology(ALGN.US$ - up 11.5%
2. $Textron(TXT.US$ - up 5.2%
3. $STMicroelectronics(STM.US$ - up 4.1%
4. $Lam Research(LRCX.US$ - up 3.9%
5. $RELX PLC(RELX.US$ - up 3.1%
6. $Royal Caribbean(RCL.US$ - up 3.1%
7. $Micron Technology(MU.US$ - up 3.1%
8. $Western Digital(WDC.US$ - up 2.9...
Gap Ups
1. $Align Technology(ALGN.US$ - up 11.5%
2. $Textron(TXT.US$ - up 5.2%
3. $STMicroelectronics(STM.US$ - up 4.1%
4. $Lam Research(LRCX.US$ - up 3.9%
5. $RELX PLC(RELX.US$ - up 3.1%
6. $Royal Caribbean(RCL.US$ - up 3.1%
7. $Micron Technology(MU.US$ - up 3.1%
8. $Western Digital(WDC.US$ - up 2.9...
+17
18
Pre-Market Stock Movers
Gapping up
$Align Technology(ALGN.US$
(The orthodontics company surged 14% after posting adjusted earnings late Wednesday of $2.22 per share for the second quarter, beating estimates of $2.03 per share, according to Refinitiv. Revenue for the quarter also topped estimates, and revenue guidance for the year was above analyst expectations.)
$Meta Platforms(META.US$
(The Facebook parent jumped ne...
Gapping up
$Align Technology(ALGN.US$
(The orthodontics company surged 14% after posting adjusted earnings late Wednesday of $2.22 per share for the second quarter, beating estimates of $2.03 per share, according to Refinitiv. Revenue for the quarter also topped estimates, and revenue guidance for the year was above analyst expectations.)
$Meta Platforms(META.US$
(The Facebook parent jumped ne...
17
Read more